HSIC
62
-3
ZTS
25
2
FITB
72
2
AEE
58
3
DVN
40
-2
XYL
35
2
ZBH
45
3
FTI
61
-2
MMC
60
3
ROST
70
2
OMC
55
-7
PLD
33
3
SWKS
56
8
EXC
53
3
URBN
54
2
SO
53
5
PEG
50
4
EQT
51
-5
GT
39
2
MTB
75
2
HSIC
62
-3
ZTS
25
2
FITB
72
2
AEE
58
3
DVN
40
-2
XYL
35
2
ZBH
45
3
FTI
61
-2
MMC
60
3
ROST
70
2
OMC
55
-7
PLD
33
3
SWKS
56
8
EXC
53
3
URBN
54
2
SO
53
5
PEG
50
4
EQT
51
-5
GT
39
2
MTB
75
2
Financhill
Back

Duolingo, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
33

DUOL
Duolingo, Inc.

Last Price:
$180.68
Seasonality Move:
17.91%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.7200
Seasonality Move:
33.23%
Sell
33
Duolingo, Inc. (DUOL) is a Sell

Is Duolingo, Inc. a Buy, Sell or Hold?

  • The current Duolingo, Inc. [DUOL] share price is $180.69. The Score for DUOL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • DUOL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DUOL Stock Price Chart

What is Duolingo, Inc.'s stock price today?

  • The Duolingo, Inc. share price today is $180.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUOL is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

DUOL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.84 Sell
Relative Strength Index (14 RSI): 37.75 Sell
Chaikin Money Flow: 297749 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (176.29 - 197.11) Sell
Bollinger Bands (100): (205.96 - 333.08) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

DUOL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 183.86 Sell
20-day SMA: 190.2 Sell
50-day SMA: 222.3 Sell
200-day SMA: 336.41 Sell
8-day EMA: 184.72 Sell
20-day EMA: 190.67 Sell
50-day EMA: 218.87 Sell
200-day EMA: 294.95 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Duolingo, Inc. Earnings Growth & DUOL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.83 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.46 per share, and a decrease next year of $3.95 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Duolingo, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):